236 related articles for article (PubMed ID: 36944052)
1. Outpatient antibiogram and predictors of ciprofloxacin and trimethoprim-sulfamethoxazole resistant urinary tract infections.
Valentine-King M; Zoorob R; Grigoryan L; Trautner B
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944052
[TBL] [Abstract][Full Text] [Related]
2. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Trimethoprim and Sulfamethoxazole-Resistant Escherichia Coli in ED Patients with Urinary Tract Infections.
Wesolek JL; Wu JY; Smalley CM; Wang L; Campbell MJ
Am J Emerg Med; 2022 Jun; 56():178-182. PubMed ID: 35405469
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department.
Filiatrault L; McKay RM; Patrick DM; Roscoe DL; Quan G; Brubacher J; Collins KM
CJEM; 2012 Sep; 14(5):295-305. PubMed ID: 22967697
[TBL] [Abstract][Full Text] [Related]
6. Determining a urinary-specific antibiogram and risk factors of trimethoprim/sulfamethoxazole, ciprofloxacin and multidrug resistance among Enterobacterales in primary care.
Valentine-King M; Hansen MA; Zoorob R; Schlueter M; Matas JL; Willis SE; Danek LCK; Muldrew K; Zare M; Hudson F; Atmar RL; Chou A; Trautner BW; Grigoryan L
J Antimicrob Chemother; 2024 Mar; 79(3):559-563. PubMed ID: 38217846
[TBL] [Abstract][Full Text] [Related]
7. Community-Acquired Uropathogenic
Carmona-Cartaya Y; Hidalgo-Benito M; Borges-Mateus LM; Pereda-Novales N; González-Molina MK; Quiñones-Pérez D
MEDICC Rev; 2022 May; 24(2):20-25. PubMed ID: 35648059
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
[TBL] [Abstract][Full Text] [Related]
10. Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients.
McGregor JC; Elman MR; Bearden DT; Smith DH
BMC Fam Pract; 2013 Feb; 14():25. PubMed ID: 23433241
[TBL] [Abstract][Full Text] [Related]
11. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy.
Perfetto EM; Keating K; Merchant S; Nichols BR
J Manag Care Pharm; 2004; 10(1):17-25. PubMed ID: 14720102
[TBL] [Abstract][Full Text] [Related]
12. Outpatient Antibiotic Resistance Patterns of Escherichia coli Urinary Isolates Differ by Specialty Type.
Frisbie L; Weissman SJ; Kapoor H; D'Angeli M; Salm A; Radcliff J; Rabinowitz P
Microbiol Spectr; 2022 Aug; 10(4):e0237321. PubMed ID: 35727039
[TBL] [Abstract][Full Text] [Related]
13. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
[TBL] [Abstract][Full Text] [Related]
14. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010.
Sanchez GV; Master RN; Karlowsky JA; Bordon JM
Antimicrob Agents Chemother; 2012 Apr; 56(4):2181-3. PubMed ID: 22252813
[TBL] [Abstract][Full Text] [Related]
15. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15.
Delisle G; Quach C; Domingo MC; Boudreault AA; Gourdeau M; Bernatchez H; Lavallée C
J Antimicrob Chemother; 2016 Dec; 71(12):3562-3567. PubMed ID: 27494927
[TBL] [Abstract][Full Text] [Related]
16. High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020.
Salm J; Salm F; Arendarski P; Kramer TS
Euro Surveill; 2022 Jul; 27(30):. PubMed ID: 35904060
[TBL] [Abstract][Full Text] [Related]
17. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.
Karlowsky JA; Kelly LJ; Thornsberry C; Jones ME; Sahm DF
Antimicrob Agents Chemother; 2002 Aug; 46(8):2540-5. PubMed ID: 12121930
[TBL] [Abstract][Full Text] [Related]
18. TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANCE AND FOSFOMYCIN SUSCEPTIBILITY RATES IN UNCOMPLICATED URINARY TRACT INFECTIONS: TIME TO CHANGE THE ANTIMICROBIAL PREFERENCES.
Guneysel O; Suman E; Ozturk TC
Acta Clin Croat; 2016 Mar; 55(1):49-57. PubMed ID: 27333718
[TBL] [Abstract][Full Text] [Related]
19. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
[TBL] [Abstract][Full Text] [Related]
20. High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.
Arredondo-García JL; Amábile-Cuevas CF
J Infect Dev Ctries; 2008 Oct; 2(5):350-3. PubMed ID: 19745501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
